Armistice Capital, LLC Argenx Se Transaction History

Armistice Capital, LLC

  • $6.02 Billion
  • Q3 2024

A detailed history of Armistice Capital, LLC transactions in Argenx Se stock. As of the latest transaction made, Armistice Capital, LLC holds 152,000 shares of ARGX stock, worth $85.8 Million. This represents 1.37% of its overall portfolio holdings.

Number of Shares
152,000
Previous 200,000 24.0%
Holding current value
$85.8 Million
Previous $86 Million 4.15%
% of portfolio
1.37%
Previous 1.12%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$434.22 - $551.9 $20.8 Million - $26.5 Million
-48,000 Reduced 24.0%
152,000 $82.4 Million
Q2 2024

Aug 14, 2024
SELL
$356.01 - $451.55 $22.8 Million - $28.9 Million
-64,000 Reduced 24.24%
200,000 $86 Million
Q1 2024

May 15, 2024
SELL
$356.95 - $413.29 $19.3 Million - $22.3 Million
-54,000 Reduced 16.98%
264,000 $104 Million
Q4 2023

Feb 13, 2024
BUY
$338.91 - $506.01 $40 Million - $59.7 Million
118,000 Added 59.0%
318,000 $121 Million
Q2 2023

Aug 14, 2023
SELL
$360.14 - $422.58 $8.64 Million - $10.1 Million
-24,000 Reduced 10.71%
200,000 $77.9 Million
Q1 2023

May 15, 2023
BUY
$334.23 - $403.65 $18 Million - $21.8 Million
54,000 Added 31.76%
224,000 $83.5 Million
Q4 2022

Feb 14, 2023
BUY
$342.17 - $402.31 $17.1 Million - $20.1 Million
50,000 Added 41.67%
170,000 $64.4 Million
Q3 2022

Nov 14, 2022
SELL
$343.2 - $395.75 $23.3 Million - $26.9 Million
-68,000 Reduced 36.17%
120,000 $42.4 Million
Q2 2022

Aug 15, 2022
SELL
$269.58 - $378.88 $3.23 Million - $4.55 Million
-12,000 Reduced 6.0%
188,000 $71.2 Million
Q1 2022

May 16, 2022
BUY
$254.45 - $351.06 $3.05 Million - $4.21 Million
12,000 Added 6.38%
200,000 $63.1 Million
Q4 2021

Feb 14, 2022
SELL
$272.01 - $353.03 $5.44 Million - $7.06 Million
-20,000 Reduced 9.62%
188,000 $65.8 Million
Q3 2021

Nov 15, 2021
BUY
$295.0 - $350.58 $8.85 Million - $10.5 Million
30,000 Added 16.85%
208,000 $62.8 Million
Q2 2021

Aug 16, 2021
BUY
$257.11 - $319.92 $7.2 Million - $8.96 Million
28,000 Added 18.67%
178,000 $53.6 Million
Q1 2021

May 17, 2021
BUY
$268.3 - $380.31 $18.8 Million - $26.6 Million
70,000 Added 87.5%
150,000 $41.3 Million
Q4 2020

Feb 16, 2021
SELL
$248.13 - $308.36 $1.24 Million - $1.54 Million
-5,000 Reduced 5.88%
80,000 $23.5 Million
Q3 2020

Nov 16, 2020
BUY
$215.51 - $272.51 $3.66 Million - $4.63 Million
17,000 Added 25.0%
85,000 $22.3 Million
Q2 2020

Aug 14, 2020
BUY
$127.44 - $232.72 $8.67 Million - $15.8 Million
68,000 New
68,000 $15.3 Million

Others Institutions Holding ARGX

# of Institutions
400
Shares Held
30.9M
Call Options Held
376K
Put Options Held
489K
View Full List

About ARGENX SE

ARGX Quotes by TradingView
  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $31.2B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Armistice Capital, LLC Portfolio

Follow Armistice Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email